CA2870353C - Compositions et methodes de traitement servant a traiter et diagnostiquer des troubles oculaires - Google Patents

Compositions et methodes de traitement servant a traiter et diagnostiquer des troubles oculaires Download PDF

Info

Publication number
CA2870353C
CA2870353C CA2870353A CA2870353A CA2870353C CA 2870353 C CA2870353 C CA 2870353C CA 2870353 A CA2870353 A CA 2870353A CA 2870353 A CA2870353 A CA 2870353A CA 2870353 C CA2870353 C CA 2870353C
Authority
CA
Canada
Prior art keywords
subject
composition
agent
compound
faf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2870353A
Other languages
English (en)
Other versions
CA2870353A1 (fr
Inventor
Shelley Romayne BOYD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Translatum Medicus Inc
Original Assignee
Translatum Medicus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Translatum Medicus Inc filed Critical Translatum Medicus Inc
Priority to CA2870353A priority Critical patent/CA2870353C/fr
Publication of CA2870353A1 publication Critical patent/CA2870353A1/fr
Application granted granted Critical
Publication of CA2870353C publication Critical patent/CA2870353C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Abstract

Il est décrit des méthodes, des composés et des compositions utiles pour le diagnostic, le traitement et la prévention dun trouble oculaire, ainsi que la découverte dagents qui combattent de tels troubles de façon efficace.
CA2870353A 2014-11-06 2014-11-06 Compositions et methodes de traitement servant a traiter et diagnostiquer des troubles oculaires Active CA2870353C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2870353A CA2870353C (fr) 2014-11-06 2014-11-06 Compositions et methodes de traitement servant a traiter et diagnostiquer des troubles oculaires

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2870353A CA2870353C (fr) 2014-11-06 2014-11-06 Compositions et methodes de traitement servant a traiter et diagnostiquer des troubles oculaires

Publications (2)

Publication Number Publication Date
CA2870353A1 CA2870353A1 (fr) 2016-05-06
CA2870353C true CA2870353C (fr) 2022-01-18

Family

ID=55867677

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2870353A Active CA2870353C (fr) 2014-11-06 2014-11-06 Compositions et methodes de traitement servant a traiter et diagnostiquer des troubles oculaires

Country Status (1)

Country Link
CA (1) CA2870353C (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180221339A1 (en) * 2015-06-16 2018-08-09 Translatum Medicus, Inc. Compositions and methods for treating and diagnosing ocular disorders
EP3990433A4 (fr) 2019-06-25 2023-07-26 Translatum Medicus Inc. Procédés de fabrication d'acide 2-((1-benzyl-1h-indazol-3-yl)méthoxy)-2-méthylpropanoïque et de ses dérivés

Also Published As

Publication number Publication date
CA2870353A1 (fr) 2016-05-06

Similar Documents

Publication Publication Date Title
US11110184B2 (en) Methods for treating and diagnosing blinding eye diseases
AU2016219703B2 (en) Methods for treating and diagnosing blinding eye diseases
US20180338952A1 (en) Compositions and methods for treating and diagnosing ocular disorders
US20190336482A1 (en) Compositions and methods for treating and diagnosing ocular disorders
CA2870353C (fr) Compositions et methodes de traitement servant a traiter et diagnostiquer des troubles oculaires

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20191031